409 related articles for article (PubMed ID: 8144914)
1. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
[TBL] [Abstract][Full Text] [Related]
2. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
Jackson J; Sim RB; Whaley K; Feighery C
J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
[TBL] [Abstract][Full Text] [Related]
4. Hereditary and acquired deficiencies of C1 inhibitor.
Davis AE
Immunodefic Rev; 1989; 1(3):207-26. PubMed ID: 2698641
[TBL] [Abstract][Full Text] [Related]
5. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema.
Binkley KE; Davis A
J Allergy Clin Immunol; 2000 Sep; 106(3):546-50. PubMed ID: 10984376
[TBL] [Abstract][Full Text] [Related]
6. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
7. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
8. Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with a duplication in exon 8.
Ernst SC; Circolo A; Davis AE; Gheesling-Mullis K; Fliesler M; Strunk RC
J Immunol; 1996 Jul; 157(1):405-10. PubMed ID: 8683145
[TBL] [Abstract][Full Text] [Related]
9. Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.
Zahedi R; Bissler JJ; Davis AE; Andreadis C; Wisnieski JJ
J Clin Invest; 1995 Mar; 95(3):1299-305. PubMed ID: 7883978
[TBL] [Abstract][Full Text] [Related]
10. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
11. C1-inhibitor--biochemical properties and clinical applications.
Al-Abdullah IH; Greally J
Crit Rev Immunol; 1985; 5(4):317-30. PubMed ID: 3899511
[TBL] [Abstract][Full Text] [Related]
12. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.
Smith MA; Kerr MA
Immunology; 1985 Nov; 56(3):561-70. PubMed ID: 2934317
[TBL] [Abstract][Full Text] [Related]
14. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
[TBL] [Abstract][Full Text] [Related]
15. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.
Zahedi R; Wisnieski J; Davis AE
J Immunol; 1997 Jul; 159(2):983-8. PubMed ID: 9218620
[TBL] [Abstract][Full Text] [Related]
16. [Angioedema due to acquired complement-C1-inhibitor deficiency in a female patient with non-Hodgkin lymphoma and autoimmune hemolytic anemia].
Beretta KR; Späth PJ; Pedrazzini A; Martinelli G; Cavalli F
Schweiz Med Wochenschr; 1991 Jun; 121(25):943-7. PubMed ID: 1862309
[TBL] [Abstract][Full Text] [Related]
17. Hereditary angioedema with normal C1-inhibitor activity in women.
Bork K; Barnstedt SE; Koch P; Traupe H
Lancet; 2000 Jul; 356(9225):213-7. PubMed ID: 10963200
[TBL] [Abstract][Full Text] [Related]
18. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor.
Gadek JE; Hosea SW; Gelfand JA; Santaella M; Wickerhauser M; Triantaphyllopoulos DC; Frank MM
N Engl J Med; 1980 Mar; 302(10):542-6. PubMed ID: 7351888
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
Katz Y; Strunk RC
J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
[TBL] [Abstract][Full Text] [Related]
20. [Formation of IgG antibodies to C1 inhibitor as the cause of life-threatening angioedema].
Bork K; Alsenz J; Böckers M; Noah E; Loos M
Dtsch Med Wochenschr; 1987 Mar; 112(13):503-6. PubMed ID: 3829929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
